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Cardiorespiratory fitness (CRF) is related to 
the integrated function of numerous 
physiological systems, including the 
circulatory, respiratory, and musculo-
skeletal, and thus is considered a reflection 
of total body health
1
. Over the past three
decades, substantial evidence has emerged 
supporting the value of CRF as a predictor 
Abstract 
Cardiorespiratory fitness (CRF) has been documented as a strong, independent predictor of non-
communicable disease and mortality in both clinical and apparently healthy populations. This well-
established relationship has impelled organizations, including the American Heart Association, to 
release scientific statements highlighting the importance of accurate quantification of CRF. Current 
knowledge of the relationship between CRF and mortality is predominantly based on estimated CRF 
obtained from varying indirect methods.  Cardiopulmonary exercise testing (CPX), the gold standard 
method of CRF measurement, provides a more accurate and reliable quantification of CRF compared 
to estimated methods. This review provides support for the diagnostic and prognostic use of CRF 
based on the current literature and makes a case for the use of CPX when available, as well as the 
need for standardization of normative values defining CRF levels to increase the efficacy of the risk 
assessment. Further, clinical applications of CPX-derived CRF are discussed, providing clinicians 
with recommendations on how to use and interpret this measure in practice to guide clinical decisions 
and improve patient outcomes. 
Key words: Cardiopulmonary exercise testing, Aerobic capacity, Exercise, Physical Fitness 
of non-communicable disease and 
premature mortality. The strong, inverse, 
and independent relationship between CRF 
and these adverse health outcomes has been 
reported in several cohorts with varying 
demographics and baseline health statuses, 
speaking to its robustness as a diagnostic 
and prognostic tool
2-5
. In fact, CRF has
been documented to be a stronger predictor 
than other traditional risk factors 
1, 3, 6
. This
established relationship prompted the 
American Heart Association (AHA) to 
publish a scientific statement in 2016 
promoting CRF as a clinical vital sign
1
.
Although the importance of CRF is well-
established, several factors need to be 
refined in order for CRF to be routinely and 
effectively incorporated in clinical practice 
(standardization, normative values defining 
fitness levels, etc.). In this review, we 
provide support for the diagnostic and 
prognostic use of CRF based on the current 
literature assessing the relationship between 
CRF and health outcomes. We also discuss 
clinical applications of CRF, providing 
clinicians with recommendations on how to 
use and interpret this measure in practice to 
increase the efficacy of the risk assessment 
and improve patient outcomes.  
1. Incorporating Cardiorespiratory 
Fitness into Practice: What Needs to be 
Refined 
The relationship between CRF and 
mortality, when studied in apparently 
healthy, disease free populations, has 
almost exclusively been studied using 
estimated CRF (CRFe). These estimates 
were obtained from various indirect 
methods, such as exercise workload or 
duration on a maximal exercise test, 
2, 3, 7, 8
heart rate at a submaximal workload 
4, 8-11
,
or more recently using non-exercise 
prediction equations
12-15
. In 2009, Kodama
et al published a meta-analysis using data 
from 33 studies to assess the quantitative 
relationship of CRF with cardiovascular 
disease (CVD) and all-cause mortality in 
apparently healthy adults. Together these 
studies utilized over 20 different methods 
for obtaining CRF, including both direct 
and indirect measurements 
16
. A more 
recent paper by Harber et al reviewed the 
research advances on this relationship since 
2009. Data were reported from studies that 
have utilized ~16 different CRF 
measurement methods
17
.  This highlights
the robust relationship between CRF and 
health outcomes, but also underscores the 
need of standardization. 
Varying criteria used to define low CRF in 
these research cohorts is also a concern, as 
it presents challenges to clinicians’ 
interpretation
18
. Some defined CRF levels
by achievement of a specific metabolic 
equivalent (MET), with the classification of 
low CRF ranging from 4 to 9 METs for 
exercise capacity 
2, 19
.  Others use cohort-
specific CRF classifications, most 
commonly tertiles (≤ 33%) 4, 9, 11, quartiles
(≤25%)14, 20, 21, and quintiles (≤20%) 3, 12.
For example, Jensen et al 
4
 report <8.3 
METs to represent low CRF in their cohort 
of men, whereas the low CRF in the cohort 
assessed by Park et al 
9
 corresponded to 
≤6.3 METs. To add to the problem, the 
majority of studies do not account for sex or 
age in the defining criteria. However, it has 
been clearly shown that CRF is influenced 
by these factors, with men typically having 
higher CRF values than women, and CRF 
progressively decreasing with age in a non-
linear fashion 
22
. The varying methods used
to obtain CRFe, along with the differing 
cohort specific criteria to define CRFe 
levels, have led to inconsistencies between 
studies in the degree of risk reduction 
associated with each increment increase in 
CRFe (8 to 35% risk reduction per MET 
increment increase 
1
) and the magnitude of
protection associated with achieving higher 
CRFe levels, all of which reduce 
generalizability of past study results. 
Kokkinos et al address this issue in a recent 
report calling for standardization of CRF 




All methods used to predict CRF have 
established estimation errors of ~1 to 2 
METs. This would equate to an error of up 
to 40% in those with low CRF (≤ 5 
METs)
23
. This variability may result from
exercise-related factors including maximal 
effort criteria, handrail use, protocol 
selection, exercise mode, i.e. 
24
. Small 
differences in CRF have been shown to 
have important clinical application as 
Kodama et al reported 1 MET increment 
increase to be associated with 13 and 15% 
reductions in risk for all-cause and CVD 
mortality
16
, respectively.  Therefore, the use
of CRFe has the potential to over- or 
underestimate one’s risk for mortality by ~ 
30%. 
Longitudinal studies have assessed the 
influence of the change in CRF over time 
(>4 years) on mortality risk, reporting 
approximately 30 to 40% reduction in risk 
by improving one’s CRF level from unfit to 
fit 
19, 25
. However, similar to prior cross-
sectional studies, these longitudinal studies 
used varying criteria to define fit and unfit 
levels, and primarily used CRFe. This may 
significantly impact the risk assessment, as 
error may be introduced into both the 
baseline and follow-up exercise tests, which 
could lessen the sensitivity of the risk 
stratification.   
The findings from these longitudinal 
analyses suggest that prescribing exercise to 
increase CRF will improve longevity. Most 
of these past studies did not directly assess 
lifestyle changes between tests. CRF is 
considered to be an objective measure of 
physical activity (PA), and it has been 
reported that 5 to 30% (1-2 MET) 
improvements in CRF typically occur 
following 3 to 6 months of an aerobic 
exercise training program, with higher 
improvements seen in those with lower 
baseline CRF 
23
. The influence of post-
training improvements in CRFe on 
prognosis has only been assessed in CVD 
patients, showing a 30% reduction in all-
cause mortality per MET increase after 12 
weeks of cardiac rehabilitation in patients 
classified as low fit at baseline. Studies are 
needed to assess the influence of short-term 
improvements in CRF following initiation 
of aerobic exercise training on mortality 
risk in apparently healthy populations.  
2. The Clinical Value of Cardio-
pulmonary Exercise Testing 
Cardiopulmonary exercise testing (CPX) 
provides direct measurement of CRF, 
expressed as maximal oxygen consumption 
(VO2max), which minimizes the exercise 
related factors that result in variability in 
the estimated methods 
24
. For example, the
use of handrails when performing a 
maximal exercise test without gas analysis 
will increase exercise test duration and 
allow the attainment of higher workloads 
(ex. speed and/or grade), which would 
result in a higher value of CRFe. As a direct 
measurement of gas exchange, CPX-
derived CRF is not altered by handrail use, 
increasing the accuracy and reliability, with 
technical and biological variability 
estimated to be only ~3 to 4% 
23
. While 
CPX has been historically underutilized due 
to requirements for additional equipment 
and trained personnel, these factors are no 
longer significant barriers. Improvements in 
technology and training, as well as the 
growing awareness of its diagnostic and 
prognostic value 
26, 27
 now allow CPX to be
considered for use more routinely in clinical 
practice.  
Hemodynamic responses to maximal 
exercise testing, including heart rate 
recovery and chronotropic incompetence 
have also been shown to have prognostic 
power. The prognostic value of these 
measures is even more evident when 
combined with CPX responses
28, 29
. CPX
can provide additional physiological 
measurements that are valuable in 
optimizing risk assessment in clinical 
populations. These measurements include 
minute ventilation (VE), ventilatory 
threshold (VT), ventilatory efficiency 
(VE/VCO2 slope), circulatory power, 
exercise ventilatory power, exercise 
oscillatory ventilation (EOV), partial 
pressure of end-tidal carbon dioxide 
(PETCO2), and oxygen uptake efficiency 
slope (OUES)
28
. Guazzi et al describe the
scientific evidence behind the value of these 
CPX variables in their 2012 
recommendations and the 2016 update 
26, 27
.
These scientific statements promote the use 
of these emerging CPX variables to 
increase diagnostic and prognostic 
sensitivity, as they allow for greater insight 
into physiological factors that cause 
functional limitations, potentially indicating 
underlying disease
1, 17, 22, 26
. For example,
VE/VCO2 slope is a commonly used 
prognostic measure with elevated VE/VCO2 
slope values (≥34 indicating decreased 
efficiency) associated with ventilation-
perfusion abnormalities commonly 
experienced by heart failure, pulmonary 
hypertension, and intrinsic lung disease 
patients. Patients’ prognosis is 
progressively worsened when VE/VCO2 
becomes ≥40 28, 30, 31. Moreover, when heart
rate recovery is combined with VE/VCO2 
slope, the multivariable score provides 
clinicians with an integrated method that 
powerfully predicts outcomes in cardiac 
patients 
29
. Continued research is needed to
gain further insight into these emerging 
CPX variables in order to increase the 
evidence-base for their clinical value. 
CPX-derived CRF has been used as a 
diagnostic and prognostic tool in clinical 
populations, with peak VO2 values < 20 
ml/kg/min warranting strong consideration 
of more aggressive medical treatment and 
<10 ml/kg/min indicating particularly poor 
prognosis. However, the use of CPX in 
apparently healthy adults, free from medical 
diagnosis of disease, is less established
27
.
To date, only one research cohort has 
assessed the relationship between CPX-
derived CRF and all-cause and disease-
specific mortality in an apparently healthy 
population. Laukkanen et al assessed the 
association of CPX-derived CRF with 




showed 20%, 31%, 12%, and 23% 
reductions in sudden cardiac death, CVD 




unit (ml/kg/min) change in CRF after 11 
years was associated with a 9% reduction in 
mortality risk in this cohort
35
. The use of
CPX-derived CRF make the findings from 
this study promising, as they confirm the 
well-established relationship between CRFe 
and mortality, but the higher accuracy and 
reliability of the method may improve the 
risk assessment for mortality outcomes. 
However, the generalizability of the results 
beyond middle-aged Finnish men is 
unknown. Therefore, research focusing on 
the association of CPX-derived CRF with 
clinical end-points, in diverse populations, 
including both healthy women and men, 
across a wide distribution of ages, ethnic 
and racial groups, geographical locations, 
and socioeconomic statuses is warranted. 
The studies will help to more accurately 
guide clinical decisions for these diverse 
populations. 
3. Clinical Application of Cardio-
pulmonary Exercise Testing 
The current literature suggests clinician 
utilization of CPX would better predict 
patient outcomes compared to estimated 
methods. Currently, variability in physician 
utilization and understanding of CRF may 
be a limiting factor, even in a physician 
office equipped with CPX equipment.   The 
Guazzi et al scientific statements provide 
clear risk stratification algorithms, using 
CPX evidence-based research results which 
can provide guidance to clinicians for both 
prognostic and diagnostic applications.  
These statements also provide algorithms 
specific to patient populations who are 
healthy, undergoing a pre-surgical 
evaluation, or with underlying pulmonary 
or cardiac abnormalities 
26, 27
.
Consequently, functional classification 
beyond evaluation of clinical populations 
(along with delineation of their unhealthy 
habits) would suggest the need for two tiers 
of disease- specific patients.  The first 
would be a functionally stable participant 
for a rehabilitation program, with long term 
follow-up testing. The second group 
including patients in the pre-surgical or pre-
treatment (such as toxic chemotherapy) 
phase, with their post-surgical or post-
treatment outcome.  The goal in this group 
would be an eventual transition to a more 
conventional rehabilitation program when 
more acute goals are achieved.  
Measurement of CPX-derived CRF in the 
pre- and post-phases would provide a more 
objective and accurate reflection of the 
change in CRF in response to their overall 
treatment, including lifestyle behavioral 
modifications. 
There remains a distinct discrepancy 
between the value of CPX and a clinician’s 
utilization of the service. Enthusiasm for 
the ability to assess risk and detect 
underlying disease based on clinical 
variables obtained from CPX, as well as the 
possibility to change a patient’s prognosis 
by improving CRF through a fitness 
program should herald a change in 
physician interest. Previously, there was 
high physician hesitation for ordering an 
exercise test, out of their concern for patient 
discomfort or anxiety. However, current 
standard-of-care procedures can be more 
intensive, while only providing risk 
evaluation similar to CPX outcomes.  A few 
of these include cardiac stress tests with or 
without intravenous catheter placement, 
mammography, 24-hour gastric pH probes, 
colonoscopies and esophagogastroscopy. 
Therefore, the physician hesitations towards 
the use of CPX should be reconsidered, as it 
provides a wealth of clinical information 
and significantly adds to the risk assessment 
with minimal risk to the individual
23
.
The establishment of the Fitness Registry 
and the Importance of Exercise National 
Database, called for by the American Heart 
Association in 2013, allows physicians to 
more easily interpret non-communicable 
disease and mortality risk based on CPX 
derived CRF. This registry provides 
population based age and sex-specific 
reference values developed from > 12,000 
CPX tests 
22, 37
,  increasing generalizability
of CRF percentiles to the US adult 
population that physicians see on a regular 
basis. The use of CPX-derived CRF along 
with age and sex-specific reference values 
from the FRIEND registry would reduce 
inconsistencies between studies and help 
ease clinician interpretation of risk. 
4. Conclusion  
CRF has been shown to reflect total body 
health and has important prognostic and 
diagnostic value. Clinicians should assess 
CRF routinely as a vital sign, which can 
easily be done with CRFe methods. CPX-
derived CRF provides the most accurate 
data, which will reduce misclassification of 
risk, thus it should be increasingly 
considered for use in clinical practice. A 
wealth of clinical information is also 
obtained through the measurement of CPX 
variables which increase prognostic power 
when combined with CRF and 
hemodynamic measures.  When used, CPX-
derived CRF can be interpreted with age 
and sex-specific reference standards from 
the FRIEND registry, which should help 
guide clinical decisions. Those identified 
with low CRF, via the routine CRF 
assessments, should be recommended for 
therapy (i.e. regular exercise training), 
similar to how clinicians currently respond 
by prescribing therapies for other CVD risk 
factors.   
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